Patient Basic Information Patient: Mr. John (John Harris) Nationality: Mauritania Disease Diagnosis: Blue Eyes Clinical Hospital: H0H0 treatment: Targeted treatment + Immunotherapy Accommodation days: 180 days Treatment cost: about 48373 yuan Treatment effect: Obvious improvement Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process. After 180 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the hospital standard.
The patient's treatment resulted in a marked improvement. At the time of his discharge, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to track recovery through the remote follow-up system. 'Mr.
John has criticized this case as a typical case of cross-border suspected seriousness clinical disease. The multi-disciplinary collaborative mechanism of the CH4 based on the development of targeted treatment + immunotherapy for the blue eye reflects the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and is a shorthand for the regulation of the international delivery of medical services. (Figure is taken from the official news report of CH5 and medical scenarios)